In particular, polymorphisms in MMP9 and TGFB1 are proposed to protect against centrilobular emphysema, and polymorphisms in TIMP2 and TNF seem to increase the risk for paraseptal emphysema and/or airflow obstruction. This evidence concerns the gene MMP9 and pulmonary emphysema.